1. FDA. FDA approves olaparib for adjuvant treatment of high-risk early breast cancer. Available at: https://www.fda.gov/drugs/resources-information-approved-drugs/fdaapproves-olaparib-adjuvant-treatment-highrisk-early-breast-cancer. Accessed October 3, 2023.
2. NHS strikes landmark deal for drug to treat two most common cancers. NHS News. Available at: https://www.england.nhs.uk/2023/04/nhs-strikes-landmark-deal-for-drug-to-treat-two-most-common-cancers/. Published April 6, 2023. Accessed August 2, 2023.
3. Population health management in radiology: economic considerations;Dako;J Am Coll Radiol,2023
4. The impact of downstream procedures on lung cancer screening adherence;Tailor;J Am Coll Radiol,2023
5. Repeat annual lung cancer screening after baseline screening among screen-negative individuals: no-cost coverage is not enough;Tailor;J Am Coll Radiol,2023